Skip to content

MEDISERVICES: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MEDISERVICES

BE 0533.803.668
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€350
2024 · -€9,015+€9,365
Equity
-€109,592
2024 · -€109,941+€350
Cash
€3,732
2024 · €329+€3,403
Balance sheet total
€358,197
2024 · €352,894+€5,303

Largest movements

2024 to 2025
Assets

No asset line moved by more than 1% of the balance sheet total.

    Equity and liabilities
    • Other debts +€33,301

      up €33,301 (+16.4%), from €202,851 to €236,152

    • Debts after one year -€24,137

      down €24,137 (-12.0%), from €200,433 to €176,296

      of which Financial debts: -€24,137

    Income statement
    • Financial charges -€4,665

      down €4,665 (-14.3%), from €32,642 to €27,977

    • Gross operating margin -€4,066

      down €4,066 (-8.2%), from €49,369 to €45,303

    • Depreciation +€1,317

      up €1,317 (+10.9%), from €12,041 to €13,358

    From the 2024 result to the 2025 result

    effect on the result

    Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

    Result 2024 -€9,015
    Gross operating margin -€4,066
    Depreciation -€1,317
    Other operating charges +€218
    Other operating items +€9,865
    Financial charges +€4,665
    Result 2025 €350
    raises the resultlowers the resultnot broken down further in the accounts

    Derived cash bridge

    cash 2024 to 2025

    Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

    From operations +€42,585
    Investment -€15,991
    Financing -€23,191
    Cash 2024 €329
    Net result for the year +€350
    Depreciation +€13,358
    Receivables within one year +€735
    Deferred charges and accrued income -€2
    Trade debts -€2,215
    Tax, wage and social debts +€505
    Other debts +€33,301
    Accrued charges and deferred income -€3,447
    Investment in fixed assets (net) -€15,991
    Debts after one year -€24,137
    Current portion of long-term debt +€947
    Cash 2025 €3,732
    brings cash intakes cash out
    Every line side by side 40 lines
    Line Code 2024 2025 Change %
    Total assets 20/58 €352,894 €358,197 +€5,303 +1.5%
    Fixed assets 21/28 €351,275 €353,908 +€2,633 +0.7%
    Tangible fixed assets 22/27 €351,275 €353,908 +€2,633 +0.7%
    Land and buildings 22 €336,614 €325,177 -€11,437 -3.4%
    Plant, machinery and equipment 23 €4,661 €28,731 +€24,070 +516%
    Assets under construction and advance payments 27 €10,000 €0 -€10,000 -100%
    Current assets 29/58 €1,619 €4,289 +€2,670 +165%
    Amounts receivable within one year 40/41 €1,043 €307 -€735 -70.5%
    Trade receivables 40 €1,043 €307 -€735 -70.5%
    Other amounts receivable 41 €0 - =
    Cash at bank and in hand 54/58 €329 €3,732 +€3,403 +1,035%
    Deferred charges and accrued income 490/1 €247 €249 +€2 +0.7%
    Total equity and liabilities 10/49 €352,894 €358,197 +€5,303 +1.5%
    Equity 10/15 -€109,941 -€109,592 +€350 +0.3%
    Contributions 10/11 €6,200 €6,200 = 0.0%
    Profit (loss) carried forward 14 -€116,141 -€115,792 +€350 +0.3%
    Amounts payable 17/49 €462,835 €467,789 +€4,954 +1.1%
    Amounts payable after more than one year 17 €200,433 €176,296 -€24,137 -12.0%
    Financial debts 170/4 €75,433 €51,296 -€24,137 -32.0%
    Other amounts payable 178/9 €125,000 €125,000 = 0.0%
    Amounts payable within one year 42/48 €234,806 €267,344 +€32,538 +13.9%
    Current portion of amounts payable after more than one year 42 €23,191 €24,137 +€947 +4.1%
    Financial debts 43 €0 - =
    Credit institutions 430/8 €0 - =
    Trade debts 44 €5,883 €3,668 -€2,215 -37.6%
    Suppliers 440/4 €5,883 €3,668 -€2,215 -37.6%
    Taxes, remuneration and social security 45 €2,882 €3,387 +€505 +17.5%
    Taxes 450/3 €2,882 €3,387 +€505 +17.5%
    Other amounts payable 47/48 €202,851 €236,152 +€33,301 +16.4%
    Accrued charges and deferred income 492/3 €27,596 €24,149 -€3,447 -12.5%
    Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €12,041 €13,358 +€1,317 +10.9%
    Other operating charges 640/8 €2,498 €2,280 -€218 -8.7%
    Non-recurring operating charges 66A €11,204 €1,338 -€9,865 -88.1%
    Gross operating margin 9900 €49,369 €45,303 -€4,066 -8.2%
    Operating profit (loss) 9901 €23,627 €28,327 +€4,700 +19.9%
    Financial charges 65/66B €32,642 €27,977 -€4,665 -14.3%
    Recurring financial charges 65 €32,642 €27,977 -€4,665 -14.3%
    Profit (loss) for the period before taxes 9903 -€9,015 €350 +€9,365
    Profit (loss) for the period 9904 -€9,015 €350 +€9,365
    Profit (loss) for the period to be appropriated 9905 -€9,015 €350 +€9,365

    Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.